Published in J Neurosurg on July 01, 1996
Monstrous crablike hypertrophy of the cerebellar vermis. J Neurosurg (1997) 0.75
Hereditary angioedema: its diagnostic and management perspectives. Am J Med (1990) 2.50
A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50
Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg (2001) 2.38
Introducing a drug formulary to general practice--effects on practice prescribing costs. J R Coll Gen Pract (1987) 2.24
Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation. Nature (1979) 2.17
Quantitative evaluation of a screening program. Am J Public Health (1974) 2.00
Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med (1996) 1.75
Contribution of general practitioner hospitals in Scotland. Br Med J (Clin Res Ed) (1984) 1.74
Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol (1979) 1.72
A closer look at water-related geologic activity on Mars. Science (2007) 1.71
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest (1992) 1.66
Volatile and organic compositions of sedimentary rocks in Yellowknife Bay, Gale crater, Mars. Science (2013) 1.65
Community hospitals--time to come off the fence. J R Coll Gen Pract (1989) 1.57
Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2. Virology (1990) 1.52
Hydrated silicate minerals on Mars observed by the Mars Reconnaissance Orbiter CRISM instrument. Nature (2008) 1.52
Refractory cholinergic urticaria successfully treated with ketotifen. J Allergy Clin Immunol (1989) 1.52
Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood (2000) 1.51
RANTES is a chemotactic and activating factor for human eosinophils. J Immunol (1993) 1.49
Genetic variation among dengue 2 viruses of different geographic origin. Virology (1983) 1.48
Respiratory viruses induce production of histamine-releasing factor by mononuclear leukocytes: a possible role in the mechanism of virus-induced asthma. J Infect Dis (1991) 1.43
Partial nucleotide sequence of St. Louis encephalitis virus RNA: structural proteins, NS1, ns2a, and ns2b. Virology (1987) 1.34
Macrophage inflammatory protein-1 alpha activates basophils and mast cells. J Exp Med (1992) 1.27
Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. J Virol (1984) 1.26
The intrinsic helix-forming tendency of L-alanine. Proc Natl Acad Sci U S A (1992) 1.26
Complement-mediated release of histamine from human leukocytes. J Immunol (1975) 1.20
Personal accounts of the role of God in health and illness among older rural African American and White residents. J Cross Cult Gerontol (2000) 1.17
Histamine-releasing activity (HRA). II. Interaction with basophils and physicochemical characterization. J Immunol (1979) 1.15
Elemental geochemistry of sedimentary rocks at Yellowknife Bay, Gale crater, Mars. Science (2013) 1.14
Genetic variation and microevolution of dengue 2 virus in Southeast Asia. Virology (1989) 1.13
Spinal lipomas in children: outcome of 270 procedures. Pediatr Neurosurg (1997) 1.11
Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets. Br J Pharmacol (1980) 1.10
Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J Allergy Clin Immunol (1997) 1.08
Geographic classification of dengue-2 virus strains by antigen signature analysis. Virology (1986) 1.08
Mindfulness meditation-related pain relief: evidence for unique brain mechanisms in the regulation of pain. Neurosci Lett (2012) 1.08
'Idiopathic' nephrotic syndrome is not always idiopathic. Tex Med (1990) 1.07
Complement-mediated release of histamine from human basophils. II. Biochemical characterization of the reaction. J Immunol (1976) 1.05
In situ radiometric and exposure age dating of the martian surface. Science (2013) 1.03
The Opportunity Rover's Athena science investigation at Meridiani Planum, Mars. Science (2004) 1.03
High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med (1996) 1.02
Partial amino acid sequences of chicken and turkey immunoglobulin light chains. Homology with mammalian lambda chains. Biochemistry (1971) 0.99
Developmental disorders of the pediatric spine. Radiol Clin North Am (1991) 0.98
A comparison of New World alphaviruses in the western equine encephalomyelitis complex by immunochemical and oligonucleotide fingerprint techniques. J Gen Virol (1980) 0.98
Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells. J Immunol (1989) 0.98
Release of slow reacting substance of anaphylaxis from human leukocytes. J Immunol (1974) 0.97
Positive interaction between agonists in the aggregation response of human blood platelets: interation between ADP, adrenaline and vasopressin. Br J Haematol (1980) 0.95
The Spirit Rover's Athena science investigation at Gusev Crater, Mars. Science (2004) 0.92
Generation of slow reacting substance by human leukocytes. II. Comparison of stimulation by antigen, anti-IgE, calcium ionophore, and C5-peptide. J Immunol (1980) 0.92
Unsuspected benzyl alcohol hypersensitivity. N Engl J Med (1982) 0.92
Hyaluronic acid enhances cell proliferation during eosinopoiesis through the CD44 surface antigen. J Immunol (1995) 0.91
Synthesis of tentoxin and related dehydro cyclic tetrapeptides. J Org Chem (1978) 0.91
The clinical and radiological evaluation of primary brain tumors in children, Part I: Clinical evaluation. J Natl Med Assoc (1993) 0.91
MR of terminal myelocystoceles. Eur J Radiol (1995) 0.89
Dihydroergocryptine is a non-selective antagonist for human platelet alpha-adrenoreceptors. Nature (1979) 0.89
Histamine-releasing activity. IV. Molecular heterogeneity of the activity from stimulated human thoracic duct lymphocytes. Cell Immunol (1984) 0.88
N-terminal sequence heterogeneity of guinea pig anti-DNP kappa chains. Immunochemistry (1969) 0.88
Estimating educational casualty from the 1964 rubella epidemic in Maryland. Md State Med J (1972) 0.88
Identification of a histamine release inhibitory factor produced by human mononuclear cells in vitro. J Clin Invest (1988) 0.87
Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med (1995) 0.87
Recurrent diffuse osteomyelitis involving the mandible. Oral Surg Oral Med Oral Pathol (1984) 0.86
Assessment of Mars Exploration Rover landing site predictions. Nature (2005) 0.86
Detection of histamine release inhibitory factor- and histamine releasing factor-like activities in bronchoalveolar lavage fluids. Am Rev Respir Dis (1990) 0.86
Enhancement of basophil chemotaxis in vitro by virus-induced interferon. J Clin Invest (1981) 0.86
MR imaging of symptomatic neurocutaneous melanosis in children. Pediatr Radiol (1997) 0.85
N-terminal analysis of normal immunoglobulin light chains. I. A study of thirteen individual humans. Immunochemistry (1971) 0.85
Selective inhibition of the cutaneous late but not immediate allergic response to antigens by misoprostol, a PGE analog. Results of a double-blind, placebo-controlled randomized study. Am Rev Respir Dis (1993) 0.85
High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans' cells in allergen-induced late-phase cutaneous reactions in atopic subjects. Immunology (1998) 0.84
Three weeks of the limited list. Br Med J (Clin Res Ed) (1985) 0.84
Reversed in vitro anaphylaxis induced by anti-IgG: specificity of the reaction and comparison with antigen-induced histamine release. J Immunol (1972) 0.84
Activation of basophils. Fed Proc (1986) 0.84
Local chemotherapy omaduromycosis caused by Monosporium apiospermum. Arch Intern Med (1969) 0.84
Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism. J Immunol (1985) 0.83
Giant trichobezoar--an unusual case. Scott Med J (1979) 0.83
The feasibility of barcode-based dispensing quality assurance programs. Drug Intell Clin Pharm (1984) 0.83
Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med (1994) 0.83
Enhanced expression of high-affinity IgE receptor (Fc epsilon RI) alpha chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells. J Allergy Clin Immunol (1997) 0.83
Sensitivity of basophils to histamine releasing factor(s) of various origin: dependency on allergic phenotype of the donor and surface-bound IgE. J Allergy Clin Immunol (1990) 0.82
Local heat urticaria/angioedema: evidence for histamine release without complement activation. J Allergy Clin Immunol (1981) 0.82
Ultrastructural and immunohistochemical evidence for release of eosinophilic granules in vivo: cytotoxic potential in chronic eosinophilic pneumonia. J Allergy Clin Immunol (1987) 0.82
Complement-mediated release of histamine from human basophils. III. Possible regulatory role of microtubules and microfilaments. J Allergy Clin Immunol (1977) 0.82
Imaging of terminal myelocystoceles. J Natl Med Assoc (1996) 0.82
Familial paraproteinemia. Arch Intern Med (1971) 0.82
Developmental normo-maturation of brainstem auditory evoked potentials in children with asymptomatic meningo-myelocele during the first year of life. Childs Nerv Syst (1997) 0.82
Nasoethmoidal meningoencephalocele. Arch Otolaryngol (1974) 0.81
The role of complement in human immediate hypersensitivity: evidence against involvement of the alternate pathway of complement activation. J Immunol (1973) 0.81
Interleukin-8 and RANTES inhibit basophil histamine release induced with monocyte chemotactic and activating factor/monocyte chemoattractant peptide-1 and histamine releasing factor. Am J Respir Cell Mol Biol (1992) 0.81
Inactivated poliovirus vaccine and test development at Connaught Laboratories Ltd. Rev Infect Dis (1984) 0.81
Refractory exacerbations of hereditary angioedema with associated Helicobacter pylori infection. J Allergy Clin Immunol (1999) 0.81
Missing medications associated with centralized unit dose dispensing. Am J Hosp Pharm (1975) 0.81
Histamine-releasing activity (HRA). III. HRA induces human basophil histamine release by provoking noncytotoxic granule exocytosis. Clin Immunol Immunopathol (1984) 0.81
Histamine-releasing activity. V. Characterization and purification using high-performance liquid chromatography. Cell Immunol (1984) 0.80
Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma. Am J Respir Crit Care Med (1998) 0.80
Allergen-induced recruitment of Fc epsilon RI+ eosinophils in human atopic skin. Eur J Immunol (1997) 0.80
Pancam multispectral imaging results from the Spirit Rover at Gusev Crater. Science (2004) 0.80
Genetic heterogeneity among Saint Louis encephalitis virus isolates of different geographic origin. Virology (1981) 0.80
Parenteral hyperalimentation. Am J Nurs (1969) 0.80
Development of a new technique for recovery of cytokines from inflammatory sites in situ. J Immunol Methods (1992) 0.79
Interleukin-1 receptor antagonist protein inhibits the synthesis of IgE and proinflammatory cytokines by allergen-stimulated mononuclear cells. Am J Respir Cell Mol Biol (1994) 0.79
Complement-induced degranulation of human basophils. J Immunol (1981) 0.79
The clinical and radiological evaluation of primary brain neoplasms in children, Part II: Radiological evaluation. J Natl Med Assoc (1993) 0.79